Takeda Worried About Actos’s Cancer Link, Filing Shows

Takeda Pharmaceutical Co. executives were so worried in 2003 that their diabetes drug Actos might be linked to cancer that they questioned doctors on whether they would prescribe a drug that had a warning about the disease on its label, according to court filings.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.